DMKJ
JAZZ icon

David M. Knott Jr’s Jazz Pharmaceuticals JAZZ Stock Holding History

David M. Knott Jr’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,411
Closed -$2.9M – 124
2023
Q3 		$2.9M Hold
22,411
– – 1.11% 17
2023
Q2 		$2.78M Hold
22,411
– – 1.11% 21
2023
Q1 		$3.28M Hold
22,411
– – 1.29% 17
2022
Q4 		$3.57M Hold
22,411
– – 1.35% 18
2022
Q3 		$2.99M Hold
22,411
– – 1.26% 16
2022
Q2 		$3.5M Hold
22,411
– – 1.47% 15
2022
Q1 		$3.49M Sell
22,411
-1,000
-4% -$145K 1.11% 24
2021
Q4 		$2.98M Buy
+23,411
New +$3.08M 1.01% 28

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

David M. Knott Jr's JAZZ Position: Q4 2023 in Review

David M. Knott Jr sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 22,411 shares — an estimated $2.9M sold.

David M. Knott Jr first reported a position in JAZZ in Q4 2021 and held it in 8 quarters. The position peaked at $3.57M in Q4 2022. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • David M. Knott Jr reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • David M. Knott Jr sold 22,411 Jazz Pharmaceuticals shares in Q4 2023, an estimated $2.9M.
  • David M. Knott Jr first reported a position in Jazz Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • David M. Knott Jr's Jazz Pharmaceuticals position peaked at $3.57M in Q4 2022.
  • 500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.